SpecificationsOrganism/cell line/tissueMus musculus; 60 day post-natal lens tissueSexN/ASequencer or array typeMouseWG-6 v2.0 Expression BeadChip arrays (Illumina)Data formatRawExperimental factorsMafg −/−:Mafk +/− (test) vs. Mafg +/−:Mafk +/− (control) (Both on mixed background, with contributions from the 129Sv/J, C57BL/6J, and ICR strains)Experimental featuresIdentification of differentially expressed genes in the lens of mice lacking two copies of Mafg and one copy of Mafk that exhibit lens defects with age compared to lens of mice lacking one copy of Mafg and one copy of Mafk that are normalConsentN/ASample source locationNewark, Delaware, USA

1. Direct link to deposited data {#s0005}
================================

Deposited data can be found at: <http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE65500>.

2. Experimental design, materials and methods {#s0010}
=============================================

2.1. Experimental design {#s0015}
------------------------

The eye gene discovery tool *iSyTE* [@bb0010] predicted that the small Maf transcription factor genes *Mafg* and *Mafk* are highly enriched and expressed, respectively, in the mouse lens, and may potentially function in its development or homeostasis. Indeed, we find that *Mafg* −/−:*Mafk* +/− compound mouse mutants exhibit lens defects including cataracts [@bb0005]. To investigate the molecular changes associated with this phenotype, we performed microarray-based gene expression profiling on lens tissue obtained from *Mafg* −/−:*Mafk* +/− ("test" animals that exhibit lens defects) and *Mafg* +/−:*Mafk* +/− ("control" animals that do not exhibit lens defects) mice. These microarray datasets were analyzed to identify differentially expressed genes (DEGs) that were subjected to further integrated analysis using a workflow pipeline that incorporates wild-type lens expression data from the *iSyTE* database (<http://bioinformatics.udel.edu/Research/iSyTE>), chromatin immunoprecipitation sequencing (ChIP-Seq) data on Mafg and its co-regulatory protein Nrf2, protein--protein interactions from open resource databases, as well as gene ontology enrichment and *cis*-regulatory motif analyses ([Fig. 1](#f0005){ref-type="fig"}). Together, this approach led to the prioritization of genes most relevant to the phenotype, and to the assembly of a small Maf gene regulatory network in the lens. Below, we describe these analytical procedures in detail.

2.2. Microarrays {#s0020}
----------------

Lenses were collected on post-natal day (P) 60 from *Mafg* −/−:*Mafk* +/− (test) and *Mafg* +/−:*Mafk* +/− (control) mice for microarray-based gene expression profiling. Selection of the stage for genome-wide expression profiling of mutant tissue represents an important step, because this data influences the proper interpretation of the phenotype as well as the directions of future experiments. For example, microarray profiling performed at a stage when the phenotype is already evident, and therefore well manifested, may provide differential expression data that is potentially "contaminated" with secondary gene expression changes. This presents a challenge to resolve primary expression changes from such secondary expression changes, in turn making it difficult to correlate genetic perturbations to the observed phenotype. To address this issue, the age of the animals in this analysis was selected as P60 (2 months) because at this stage, *Mafg* −/−:*Mafk* +/− compound mutants do not exhibit any overt abnormalities in the lens ([Fig. 2](#f0010){ref-type="fig"}A--B'), which are observed in these mutants at later stages ([Fig. 2](#f0010){ref-type="fig"}C--D'). Thus, analysis of lenses at P60 increases the likelihood of detecting changes in mutant gene expression that occur prior to the onset of the overt phenotype and therefore represent primary alterations. Total RNA was isolated from both test and control lenses in biological duplicates using the RNeasy Mini Kit (Qiagen). Microarrays were performed on MouseWG-6 v2.0 Expression BeadChip arrays (Illumina) using manufacturer recommended hybridization conditions. Microarray chips were scanned using the Illumina BeadArray reader.

2.3. Microarray data quality assessment {#s0025}
---------------------------------------

To assess the quality of microarray expression data, we used inbuilt 'R' functions and performed Principle Component Analysis (PCA), derived boxplots, and analyzed histograms of the array intensities of raw unprocessed and normalized processed (see below) data ([Fig. 3](#f0015){ref-type="fig"}). We observed high level of background noise in raw mutant and control datasets in all quality plots. PCA plot from processed data showed clear separation of control and mutant datasets ([Fig. 3](#f0015){ref-type="fig"}A--B). Similar results were obtained with histograms ([Fig. 3](#f0015){ref-type="fig"}C--D) and boxplots ([Fig. 3](#f0015){ref-type="fig"}E--F) analysis of raw and processed data.

2.4. Microarray data preprocessing and analysis {#s0030}
-----------------------------------------------

Microarray data processing and analysis was performed under the 'R' statistical environment (<http://www.r-project.org>/) using *lumi* package for Illumina microarray data, available through Bioconductor ([www.bioconductor.org](http://www.bioconductor.org){#ir0025}). The workflow for microarray data analysis is described in detail ([Fig. 1](#f0005){ref-type="fig"}). As first step, raw output files from Illumina Bead Studio toolkit were read using *lumi* [@bb0015] to generate a *lumiBatch* object through *lumiR.batch* function. These imported files were then preprocessed using *lumi* built-in methods, *bgAdjust* which corrects raw Illumina probe intensities followed by *rankinvariant* for normalizing these corrected intensities. The choice of *rankinvariant* was made because only a small number of genes were expected to be differentially expressed, and Illumina recommends this normalizing method for such experiments. After pre-processing, presence--absence calls were generated using built-in function of *lumi*, and probe sets with detection *p*-value of ≤ 0.05 in at least two samples were considered as significantly present and used for further downstream analysis. Finally, probe set-level experiment was converted to gene-level by selecting a single probe set with the highest median expression, from all the probe sets representing a gene.

2.5. Identification of differentially expressed genes {#s0035}
-----------------------------------------------------

*Limma* package available through Bioconductor ([www.bioconductor.org](http://www.bioconductor.org){#ir0030}) was used to identify genes that are differentially expressed (DEGs) between a mutant and control pair. To identify DEGs, a design matrix including samples from mutant and control, representing two-group microarray experiment was generated through R *model.matrix* function. This design matrix was then used to fit linear model to the expression data for each gene through built-in *lmfit* function. Next, a mutant *vs.* control contrast matrix was constructed using *makeContrasts* function, followed by computation of estimated coefficients and standard errors through *contrast.fit* function. Built-in *ebayes* method was used to compute moderated t-statistics, moderated F-statistic, and log-odds of differential expression. Finally, *write.fit* function was used to export results after adjusting *t-static p-values* by Benjamini and Hochberg method [@bb0020]. The final list of DEGs in *Mafg* −/−:*Mafk* +/− compound mouse mutants (± 1.5-fold and *p* \< 0.05, total *n* = 97) is presented in [Supplementary Table 1](#ec0005){ref-type="supplementary-material"}. These DEGs were further investigated to narrow down the list to a gene-set most relevant to our study, using publically available resources and tools as described below.

2.6. Gene ontology enrichment analysis {#s0040}
--------------------------------------

To extract biological relevance from the differentially expressed genes in *Mafg* −/−:*Mafk* +/− mutant lenses, we used a bioinformatics tool --- DAVID (Database for Annotation, Visualization and Integrated Discovery; <http://david.abcc.ncifcrf.gov>), which provides functional interpretation of genes based on gene ontology enrichment analysis, among other criteria [@bb0025]. Up- (*n* = 42) and down-regulated (*n* = 55) genes were separately analyzed by *functional annotation tool* using default parameters. Statistically enriched terms (*p*-value ≤ 0.02) with at least two gene members were considered for both up- and down-regulated genes. Several terms relevant to the lens phenotype like "acetylation", "extracellular region", and "peptidase inhibitor activity" were found to be significantly associated with down-regulated genes in *Mafg* −/−:*Mafk* +/− mutant lenses ([Supplementary Table 2](#ec0010){ref-type="supplementary-material"}). The up-regulated gene set was found to be enriched for genes belonging to "lipid biosynthetic process", "sterol biosynthetic process", "chaperone", "response to oxidative stress", "unfolded protein binding" and "negative regulation of transcription factor activity" ([Supplementary Table 2](#ec0010){ref-type="supplementary-material"}). Together this analysis provided a preliminary insight into the function of genes that are mis-regulated in the *Mafg* −/−:*Mafk* +/− mutant lenses.

2.7. *iSyTE*-based analysis for prioritization of candidates with potential function in the lens {#s0045}
------------------------------------------------------------------------------------------------

Next, to prioritize the DEGs based on their relevance to lens biology, we investigated whether they are significantly expressed or enriched in the lens using the eye gene discovery tool *iSyTE*. *iSyTE* is a resource for lens gene expression and provides an estimate of "lens-enriched" expression based on *t*-statistic computed from *in silico* comparative analysis of mouse lens microarray datasets against whole body embryonic tissue (without lens) microarray datasets [@bb0010]. *iSyTE* has led to the identification of several new genes linked to cataract [@bb0005], [@bb0010], [@bb0030], [@bb0035], [@bb0040], and to the characterization of regulators of lens development [@bb0045], [@bb0050] as well as to the development of resources for lens studies [@bb0055], [@bb0060], [@bb0065]. The *iSyTE* analysis for DEGs revealed that 84% (*n* = 55) of down-regulated genes are lens enriched, while 64% (*n* = 42) of up-regulated genes are not lens-enriched in *Mafg* −/−:*Mafk* +/− mutant lenses. A chi-square test was performed to examine whether the difference in *iSyTE*-identified lens-enriched and non-enriched genes is significant between the up-regulated and down-regulated genes in *Mafg* −/−:*Mafk* +/− mutants. A chi-square value of 425.92 at two-tailed *p-*value \< 0.0001 indicated that the *iSyTE* assigned lens-enriched genes are significantly greater in number in the down-regulated dataset compared to the up-regulated dataset of DEGs in the mutant lenses. This analysis led to the identification of 46/55 down-regulated genes that are lens-enriched according to *iSyTE*, and therefore represent candidates for future investigations.

2.8. Predictions of functional connectivity of small Mafs in the lens based on chromatin immunoprecipitation (ChIP) data analysis {#s0050}
---------------------------------------------------------------------------------------------------------------------------------

Small Maf proteins are basic leucine zipper (bZIP) transcription factors that heterodimerize with cap and collar (CNC) family proteins and regulate gene expression by directly binding to *cis*-regulatory motifs [@bb0070]. We hypothesized that it may be possible to make specific predictions of direct targets of small Mafs in the lens, based on the following logic and use of resources. First, small Maf regulatory protein partners that are relevant to the lens can be identified using *iSyTE*. Second, ChIP-Seq data on small Mafs or their co-regulatory proteins that have been performed on non-lens cells can be analyzed in the context of the lens using *iSyTE*. Third, the *Mafg* −/−:*Mafk* +/− microarray datasets that potentially contain both direct and indirect small Maf target genes, can be further analyzed in the context of the above analyses. Thus, a comparative analysis between known direct targets in previous ChIP-Seq assays on Mafg or its lens-expressed partner protein Nrf2 and the *Mafg* −/−:*Mafk* +/− lens DEGs identify candidates common to these datasets and therefore are putative direct small Maf targets in the lens. We performed this analysis by examining ChIP data for Mafg and its partner Nrf2 obtained from previous studies [@bb0075], [@bb0080], [@bb0085] and identified 36 high-priority candidates from the original 97 differentially expressed genes in *Mafg* −/−:*Mafk* +/− mutant lenses ([Supplementary Table 1](#ec0005){ref-type="supplementary-material"}). Importantly, literature-based analysis showed that 8 of these 36 high-priority candidates are linked with cataract, in turn validating this approach.

2.9. Cis-regulatory motif analysis {#s0055}
----------------------------------

To gain further insight into putative direct targets of small Mafs in the lens, we next examined *Mafg* −/−:*Mafk* +/− DEGs for the presence of potential bZIP transcription factor binding motifs such as ARE core, NF-E2, and MARE in the 2.5 kb upstream region from the transcription start site. This analysis was also performed on the lens-relevant ChIP targets identified above. Transcription factor specific position-weight matrices (PWMs) were fetched from *MotifDb R* package (version 1.6.0), which maintains an updated and comprehensive collection of publicly available motif sites. These PWMs were then used as an input for motif search through sequence matching by *matchPWM* algorithm [@bb0090], with a sequence match threshold of ≥ 80%. This led to the identification of putative bZIP transcription factor targets in the DEGs ([Supplementary Table 1](#ec0005){ref-type="supplementary-material"}).

2.10. Integration of protein--protein and other interaction-based data {#s0060}
----------------------------------------------------------------------

Next, to extract known potential protein-level associations between *Mafg* −/−:*Mafk* +/− differentially expressed genes, we analyzed molecular interactions from experimental and curated data stored in the STRING database (<http://string-db.org>/) [@bb0095]. For this analysis, we developed an in-house *Python* script to obtain high confidence interactions (score \> 0.7) between the input set consisting of the 97 DEGs (1.5-fold change, *p*-value \< 0.05) from raw (flat) files. Protein interactions belonging to different modes such as activation, binding, and post-transcriptional modification, among others, led to the identification of new edges and ultimately contributed to assembly of small Maf regulatory network in the lens. The derived network (see below) was visualized in Cytoscape (<http://www.cytoscape.org>/) [@bb0100].

3. Discussion {#s0065}
=============

3.1. Assembling a regulatory network in the lens {#s0070}
------------------------------------------------

Previously, we had proposed that integrative analysis of diverse systems-level information and traditional molecular experimental data can be used to facilitate the assembly of regulatory networks in eye development [@bb0105]. Here, using the *Mafg* −/−:*Mafk* +/− study [@bb0005] as an example, we outline in detail the various analytical methods that can be applied to identify promising targets and derive a regulatory sub-network for the lens. This analysis can be used to identify and validate direct targets of MafG using functional assays and also to test how these genes are involved mechanistically in the ocular pathology of *Mafg* −/−:*Mafk* +/− mutants. These targets include promising candidates such as *Hspb1*, which is significantly downregulated in *Mafg* −/−:*Mafk* +/− lens microarrays, is lens-enriched according to *iSyTE*, harbors a bZIP binding motif and is identified as a target of the small Maf binding partner Nrf2 in ChIP analysis. It is evident from this example that a gene expression resource for a specific cell or tissue type, such as the *iSyTE* database, is essential for effectively integrating these different datasets. To begin with, *iSyTE* led to the identification of the small Maf proteins Mafg and Mafk as potential new regulators in lens cells, a hypothesis that was proved to be correct by the analysis of *Mafg* −/−:*Mafk* +/− mouse compound mutants. Further, overlay of lens gene expression information present in *iSyTE* served to effectively and selectively provide lens relevance to the seemingly discreet information present in various publically available regulatory and molecular interaction datasets. For example, non-lens derived ChIP data could be utilized to predict putative direct targets of small Mafs in the lens because *iSyTE* could screen for only those lens-expressed candidates within these datasets that were also found to be differentially expressed in *Mafg* −/−:*Mafk* +/− mutant lenses. Similarly, *iSyTE* could select for lens-expressed protein--protein or other relevant interactions within the *Mafg* −/−:*Mafk* +/− differentially expressed gene dataset. These "lens-filtered" data, along with *cis*-regulatory motif identification and gene ontology-based functional classification allowed for the prediction of a small Maf regulatory network in the lens that indicates defects in sterol synthesis or elevated oxidative stress to contribute to the phenotype in *Mafg* −/−:*Mafk* +/− mutants. Future experiments can now be directed to test the robustness of this predicted network and to further understand how its specific perturbation may result in lens defects such as cataracts.

In sum, we outline in detail a strategy that utilized *iSyTE* to screen for lens relevant information within publically available datasets and led to the effective prioritization of *Mafg* −/−:*Mafk* +/− differentially expressed genes. It is expected that development of resources similar to *iSyTE* will allow the extension of this integrative approach to mutant microarray data in other cell or tissue types.

The following are the supplementary data related to this article.List of microarray identified differentially expressed genes in mutant lens.Functional enrichment analysis of DEGs with the tool DAVID.
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![Workflow of microarray design, data pre-processing and analysis of differentially expressed genes.](gr1){#f0005}

![Selection of mutant stage for lens microarray analysis. Light microscopy based grid imaging of lenses from (A) control and (B) *Mafg* −/−:*Mafk* +/− compound mutant mice demonstrates no opacities at post-natal stage (P)60 or 2 months (2 mo.). High-resolution scanning electron microscopy (SEM) analysis of lenses from (A') control and (B') *Mafg* −/−:*Mafk* +/− compound mutant mice confirm the absence of overt abnormalities in mutant fiber cells at stage 2 mo. However, grid imaging analysis at age 7 months (7 mo.) demonstrates that while (C) control mice have transparent lenses, (D) *Mafg* −/−:*Mafk* +/− compound mutant mice exhibit lens opacities (asterisk). SEM analysis at age 7 months demonstrates that while (C') Control lenses have normal fiber cells, (D') *Mafg* −/−:*Mafk* +/− compound mutant mice exhibit severe fiber cell defects (asterisk). Based on this analysis, the age P60 (2 mo.), when *Mafg* −/−:*Mafk* +/− compound mutant mice do not exhibit overt lens defects, was selected as the stage to perform microarrays. This is based on the consideration that microarrays at P60 will increase the likelihood of detecting gene expression changes that reflect primary alterations prior to the manifestation of overt defects that occur with age. Scale bar in B' and D' is 10 μm.](gr2){#f0010}

![Microarray expression data quality assessment plots. Comparisons of raw unprocessed and normalized processed expression intensities between arrays of mutant and control datasets. PCA plots from (A) raw and (B) processed datasets. Histograms for (C) raw and (D) processed datasets. Boxplot for (E) raw and (F) processed datasets. Key to samples in each type of analysis is given below.](gr3){#f0015}
